Cargando…
Herpes zoster in Germany: Quantifying the burden of disease
BACKGROUND: Herpes zoster (HZ) is caused by a reactivation of the varicella-zoster-virus (VZV) and mainly affects individuals aged ≥ 50 years. Vaccines have been licensed or are under development that can protect against HZ and its main complication postherpetic neuralgia (PHN). In Germany, the burd...
Autores principales: | Ultsch, Bernhard, Siedler, Anette, Rieck, Thorsten, Reinhold, Thomas, Krause, Gérard, Wichmann, Ole |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3141411/ https://www.ncbi.nlm.nih.gov/pubmed/21679419 http://dx.doi.org/10.1186/1471-2334-11-173 |
Ejemplares similares
-
Health economic evaluation of vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia in Germany
por: Ultsch, Bernhard, et al.
Publicado: (2013) -
Influence of demographic changes on the impact of vaccination against varicella and herpes zoster in Germany – a mathematical modelling study
por: Horn, Johannes, et al.
Publicado: (2018) -
Trends in herpes zoster epidemiology in Germany based on primary care sentinel surveillance data, 2005–2016
por: Zoch-Lesniak, Beate, et al.
Publicado: (2018) -
Vaccination coverage among children in Germany estimated by analysis of health insurance claims data
por: Rieck, Thorsten, et al.
Publicado: (2014) -
Assessing varicella vaccine effectiveness and its influencing factors using health insurance claims data, Germany, 2006 to 2015
por: Rieck, Thorsten, et al.
Publicado: (2017)